
Results
2
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
PharmaEssentia
Market Cap: NT$584.3b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,380.00
7D
-5.5%
1Y
242.5%
Savior Lifetec
Market Cap: NT$6.4b
Engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally.
4167
NT$19.35
7D
4.9%
1Y
9.1%